In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Circulating Nucleic Acids in Plasma/Serum III and Serum Proteomics

Edited by Edited by Dave S. B. Hoon (John Wayne Cancer Institute, Santa Monica, California) and Bret Taback (John Wayne Cancer Institute, Santa Monica, California)
Circulating Nucleic Acids in Plasma/Serum III and Serum Proteomics

Published: June 2004

Volume 1022

Learn More

Circulating Nucleic Acids in Plasma/Serum III and Serum Proteomics (CNAPS) researchers report in this volume on the biology and clinical translation of circulating nucleic acids, a new and rapidly growing field that has continued to gain momentum over the last few years.In particular, tumor-derived DNA/RNA in the plasma/serum of cancer patients has shown promise for the diagnosis and prognosis of a variety of malignancies. In the field of prenatal diagnosis, the discovery of fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal genetic analysis. Circulating nucleic acids have also been found in an increasing number of different cancer types and recently in noncancer-related pathologic conditions as well. Numerous questions still remain regarding the origin, release, clearance, clinical utility, and possible functionality of circulating nucleic acids. CNAPS III builds on the foundation of its successful predecessors. Serum proteomics is introduced as a new topic to CNAPS and is expected to provide yet another platform for breakthrough discoveries. Serum proteomics topics will address both cancer and early pregnancy.